Motley Fool Money cover image

CRISPR, Gene Therapies, and Cure Pricing Conundrums

Motley Fool Money

CHAPTER

The CRISPR Revolution: Innovation and Ethics

This chapter explores CRISPR-Cas9 technology, comparing it to molecular scissors for genetic editing and tracing its origins as a bacterial defense mechanism. It discusses both the transformative potential of CRISPR in treating genetic diseases and the significant ethical concerns surrounding its use, particularly in germline editing. The chapter highlights ongoing advancements in therapies, while addressing the challenges and risks associated with precise genetic modifications.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner